In this blog we look at 3 powerful reasons researchers outsource Whole Exome Sequencing (WES) and how it might be the right choice for your research. Across the globe researchers have been deciphering the genetic code to identify the sequences of nucleotides in the human genome that code for proteins. In many cases, they are […]
Ordering from the NINDS repository website
We are proud to be the sole distributor for the National Institute of Neurological Disorders and Stroke (NINDS). The repository contains extensive biomaterials that can be requested by scientists worldwide. The NINDS biobank stem cell collection currently contains 411 subjects, 169 of which have iPSC and 270 of which have fibroblasts and represents several neurodegenerative […]
Bulk RNA Sequencing vs. Single Cell RNA Sequencing – what’s the difference between these powerful techniques?
Bulk RNA sequencing (bulk RNA-seq) and single-cell RNA sequencing (scRNA-seq) are both methods used to study gene expression profiles in cells. The major difference between the methods lie in the scale and resolution at which they analyze gene expression. Moreover, researchers employ these techniques for different applications – this blog looks at the differences between […]
Sampled Named Twist Bioscience ProLab
Piscataway, NJ, 2023 – Sampled1 today announced that it has been named a Next-Generation Sequencing (NGS) ProLab for Twist Bioscience, a leading synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. As an NGS ProLab, Sampled can provide researchers and scientists with access to Twist […]
5 reasons why researchers are choosing to outsource CRISPR gene editing
In recent years, CRISPR-Cas9 has emerged as a revolutionary gene-editing tool that has transformed the field of precision medicine, since it offers researchers a relatively inexpensive means to edit the DNA of a cell with precision and ease.
Sampled’s Genomics Laboratory in Glasgow Launches Inaugural Project with Guardant Health
Glasgow lab will manage blood samples for the Guardant Health SHIELD lung cancer screening study in the EU. February 1, 2023 – Piscataway, NJ – Sampled1 today announced that the new genomics Sampled Lab in Glasgow, UK, has initiated a project with Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, to manage blood […]
